Key result
CMR enables reproducible, radiation-free longitudinal surveillance in congenital heart disease when echocardiography is inconclusive.
Why the study?
Although most children with congenital heart disease now reach adulthood, transfer to adult care remains a period at risk of discontinuity and delayed recognition of residual lesions, ventricular dysfunction, arrhythmias, and aortopathy.
Answers are grounded in this paper and cite their sources.
This narrative review highlights the role of cardiovascular magnetic resonance in providing continuous, reproducible longitudinal surveillance for patients with congenital heart disease from childhood into adulthood, triggered by clinical trajectory and specific lesions rather than chronological age.
Advances in paediatric cardiology, surgery and catheter intervention have enabled most children with congenital heart disease (CHD) to reach adulthood, yet transfer to adult congenital heart disease (ACHD) care remains a period at risk of discontinuity and of delayed recognition of residual lesions, ventricular dysfunction, arrhythmias and aortopathy. Cardiovascular magnetic resonance (CMR) provides radiation-free, reproducible assessment of anatomy, ventricular volumes and function, flow, shunts and myocardial tissue. This narrative review examines CMR as a tool for continuous longitudinal surveillance from childhood into adult life. Its role is not to replace echocardiography but to answer questions that echocardiography cannot resolve reliably and to provide serially comparable measurements, particularly after tetralogy of Fallot repair, in systemic right ventricles, in Fontan circulation and in coarctation of the aorta. We describe lesion-specific protocols, standardised phase-contrast acquisition and ventricular contouring that permit valid serial comparison, and the clinical, electrocardiographic, biochemical (NT-proBNP) and echocardiographic triggers that prompt earlier CMR or allow it to be deferred. CMR timing should therefore follow the lesion and the patient’s trajectory rather than chronological age, with transfer regarded as one point on a continuous surveillance pathway. Limitations include examination duration, arrhythmia, device artefacts, contrast considerations and limited access to congenital imaging expertise.
No takes yet. Share an insight, caveat, or question.
Spagos et al. (2026) conducted a review in Congenital heart disease (CHD). Cardiovascular magnetic resonance (CMR) vs. Echocardiography was evaluated. Cardiovascular magnetic resonance provides radiation-free, reproducible longitudinal surveillance in congenital heart disease from childhood to adulthood when echocardiography is inconclusive.
Synapse has enriched 10 related papers. Consider them for comparative context: